CAS 283609-79-0

Fórmula: C21H42N6O5

InChI: InChI=1S/C21H42N6O5/c1-12(2)9-14(23)19(30)27-17(11-28)21(32)25-15(7-5-6-8-22)20(31)26-16(18(24)29)10-13(3)4/h12-17,28H,5-11,22-23H2,1-4H3,(H2,24,29)(H,25,32)(H,26,31)(H,27,30)/t14-,15-,16-,17-/m0/s1

Chave InChI: YOKXDNNIFSAXBY-QAETUUGQSA-N

SMILES: CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N)N

LSKL, INhibitor of Thrombospondin (TSP-1)

CAS: 283609-79-0

Fórmula: C₂₁H₄₂N₆O₅

Pureza: 98%

Peso molecular: 458.5954

Ref: IN-DA00BCVH

LSKL, INhibitor of Thrombospondin (TSP-1)

CAS: 283609-79-0

LSKL, INhibitor of Thrombospondin (TSP-1)

Fórmula: C₂₁H₄₂N₆O₅

Pureza: ≥95%

Peso molecular: 458.6

Ref: 54-OR1110799

L-Leucyl-L-seryl-L-lysyl-L-leucinamide

Produto Controlado

CAS: 283609-79-0

Fórmula: C₂₁H₄₂N₆O₅

Cor e Forma: Neat

Peso molecular: 458.595

Ref: TR-H246500

H-Leu-Ser-Lys-Leu-NH2 trifluoroacetate salt

CAS: 283609-79-0

L-Leu-Ser-Lys-Leu-NH2 is a cyclic peptide with the amino acid sequence H-Leu-Ser-Lys-Leu. It has been shown to have receptor activity and can be used as an experimental model of growth factors. L-Leu-Ser-Lys-Leu was found to stimulate collagen synthesis in a collagen gel, which may be due to its ability to inhibit the release of growth factor β1. L-Leu-Ser Lys Leu also has anti cancer effects by inhibiting the proliferation of malignant brain cells, as well as tubulointerstitial injury and renal cell carcinoma. This compound may also have some use in treating subarachnoid hemorrhage and fetal bovine serum (FBS) for tissue culture.

Fórmula: C₂₁H₄₂N₆O₅

Pureza: Min. 95%

Peso molecular: 458.6 g/mol

Ref: 3D-FL109362